Protalix BioTherapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Protalix BioTherapeutics, Inc. Common Stock (PLX) has a 3-month relative strength percentile of 56 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.0%, relative volume 4.17×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
56 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PLX is held by 2 ETFs as of Mar 2026. Top owner: IWM at 0.01% weight, $4M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IWMiShares Russell 2000 ETF | 0.01% | $4M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PLX Jan avg: 13.65% median: 21.56% win: 75% σ: 22.71% n: 4 2022-04-12 → 2026-05-29 | PLX Feb avg: 13.93% median: 17.75% win: 75% σ: 13.17% n: 4 2022-04-12 → 2026-05-29 | PLX Mar avg: -7.31% median: -7.23% win: 50% σ: 18.93% n: 4 2022-04-12 → 2026-05-29 | PLX Apr avg: 4.83% median: -0.92% win: 40% σ: 20.83% n: 5 2022-04-12 → 2026-05-29 | PLX May avg: -15.07% median: -1.86% win: 20% σ: 22.02% n: 5 2022-04-12 → 2026-05-29 | PLX Jun avg: -3.23% median: -4.41% win: 25% σ: 4.76% n: 4 2022-04-12 → 2026-05-29 (current) | PLX Jul avg: -7.95% median: -5.22% win: 0% σ: 8.48% n: 4 2022-04-12 → 2026-05-29 | PLX Aug avg: 4.11% median: 5.44% win: 75% σ: 12.64% n: 4 2022-04-12 → 2026-05-29 | PLX Sep avg: 8.23% median: 0.92% win: 50% σ: 24.82% n: 4 2022-04-12 → 2026-05-29 | PLX Oct avg: 5.24% median: 3.68% win: 75% σ: 7.15% n: 4 2022-04-12 → 2026-05-29 | PLX Nov avg: 4.83% median: -1.39% win: 50% σ: 30.95% n: 4 2022-04-12 → 2026-05-29 | PLX Dec avg: 13.21% median: 13.59% win: 100% σ: 10.19% n: 4 2022-04-12 → 2026-05-29 |